跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NRA-OMEPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NRA-OMEPRAZOLE
Authorized
STANDARD
NRA-OMEPRAZOLE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
89cd88fd64228c06
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
89cd88fd64228c06
Drug Approval Canada Name
NRA-OMEPRAZOLE
Product Name
NRA-OMEPRAZOLE
Status
Cancelled Post Market
Status Date
2022-07-25
Original Market Date
2020-12-02
Din
02501880
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC01 OMEPRAZOLE
Atc Name
a 02 bc 01
Aig Number
0121643001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
OMEPRAZOLE (OMEPRAZOLE MAGNESIUM)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
89cd88fd64228c06
Type
Standard
Back to Health Canada Approvals